Corrado Domenico, Basso Cristina, Leoni Loira, Tokajuk Barbara, Turrini Pietro, Bauce Barbara, Migliore Federico, Pavei Andrea, Tarantini Giuseppe, Napodano Massimo, Ramondo Angelo, Buja Gianfranco, Iliceto Sabino, Thiene Gaetano
Department of Cardiac, Thoracic, and Vascular Sciences, University of Padua Medical School, Padua, Italy.
J Am Coll Cardiol. 2008 Feb 19;51(7):731-9. doi: 10.1016/j.jacc.2007.11.027.
We tested whether 3-dimensional electroanatomical voltage mapping (EVM) may help in the differential diagnosis between idiopathic right ventricular outflow tract (RVOT) tachycardia and arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D).
Right ventricular EVM has been demonstrated to reliably identify low-voltage regions ("electroanatomical scar"), which in patients with ARVC/D correspond to areas of fibrofatty myocardial replacement.
The study population comprised 27 patients (15 men and 12 women, age 33.9 +/- 8 years) with RVOT tachycardia and no echocardiographic/angiographic evidence of right ventricular (RV) dilation/dysfunction, who underwent EVM and endomyocardial biopsy (EMB) for characterization of ventricular tachycardia (VT) substrate before catheter ablation.
Electroanatomical voltage mapping was normal in 20 of 27 patients (74%, group A), with electrogram voltage >1.5 mV throughout the RV. The other 7 patients (26%, group B) showed >/=1 (1.4 +/- 07) RV electroanatomical scar area(s) (bipolar voltage <0.5 mV) that correlated with fibrofatty myocardial replacement at EMB (p < 0.001). Clinical predictors of RV scar were right precordial QRS prolongation (p < 0.001) and VT inducibility (p = 0.001). Catheter ablation successfully eliminated VT in 18 of 20 patients (90%). During a follow-up of 41 +/- 8 months, 3 of 7 patients (43%) from group B received an implantable defibrillator because of life-threatening ventricular arrhythmias, compared with no patients from group A (p = 0.016).
An early/minor form of ARVC/D may mimic idiopathic RVOT tachycardia. Electroanatomical voltage mapping is able to identify RVOT tachycardia due to concealed ARVC/D by detecting RVOT electroanatomical scars that correlate with fibrofatty myocardial replacement at EMB and predispose to sudden arrhythmic death.
我们测试了三维电解剖电压标测(EVM)是否有助于特发性右心室流出道(RVOT)心动过速与致心律失常性右心室心肌病/发育不良(ARVC/D)之间的鉴别诊断。
右心室EVM已被证明能够可靠地识别低电压区域(“电解剖瘢痕”),在ARVC/D患者中,这些区域对应于纤维脂肪性心肌替代区域。
研究人群包括27例RVOT心动过速患者(15例男性和12例女性,年龄33.9±8岁),且无右心室(RV)扩张/功能障碍的超声心动图/血管造影证据,这些患者在导管消融术前接受了EVM和心内膜活检(EMB)以表征室性心动过速(VT)基质。
27例患者中有20例(74%,A组)电解剖电压标测正常,整个右心室电图电压>1.5 mV。其他7例患者(26%,B组)显示≥1个(1.4±0.7)右心室电解剖瘢痕区域(双极电压<0.5 mV),这与EMB时的纤维脂肪性心肌替代相关(p<0.001)。右心室瘢痕的临床预测因素是右胸前导联QRS波增宽(p<0.001)和VT可诱发性(p=0.001)。20例患者中有18例(90%)导管消融成功消除了VT。在41±8个月的随访期间,B组7例患者中有3例(43%)因危及生命的室性心律失常接受了植入式除颤器,而A组无患者接受(p=0.016)。
ARVC/D的早期/轻度形式可能模仿特发性RVOT心动过速。电解剖电压标测能够通过检测与EMB时纤维脂肪性心肌替代相关且易导致心律失常性猝死的RVOT电解剖瘢痕来识别隐匿性ARVC/D所致的RVOT心动过速。